IRIS
MONDA, EMANUELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.222
AS - Asia 3.298
NA - Nord America 2.701
SA - Sud America 467
Continente sconosciuto - Info sul continente non disponibili 258
AF - Africa 53
OC - Oceania 9
Totale 13.008
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 4.906
US - Stati Uniti d'America 2.624
SG - Singapore 1.187
CN - Cina 690
VN - Vietnam 519
HK - Hong Kong 443
IT - Italia 422
BR - Brasile 388
IE - Irlanda 368
DE - Germania 168
KR - Corea 163
IN - India 108
GB - Regno Unito 107
BD - Bangladesh 37
JP - Giappone 37
AR - Argentina 36
CA - Canada 36
FR - Francia 34
FI - Finlandia 33
AT - Austria 30
MX - Messico 27
GR - Grecia 23
SE - Svezia 22
NL - Olanda 20
ZA - Sudafrica 18
EC - Ecuador 17
TR - Turchia 16
UA - Ucraina 16
CH - Svizzera 14
IQ - Iraq 13
MA - Marocco 11
PL - Polonia 11
ES - Italia 9
IR - Iran 9
PK - Pakistan 9
ID - Indonesia 8
LT - Lituania 8
SA - Arabia Saudita 8
CZ - Repubblica Ceca 7
NZ - Nuova Zelanda 7
PH - Filippine 7
EG - Egitto 6
IL - Israele 6
VE - Venezuela 6
CO - Colombia 5
JO - Giordania 5
NP - Nepal 5
UZ - Uzbekistan 5
CL - Cile 4
JM - Giamaica 4
KZ - Kazakistan 4
PE - Perù 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
CR - Costa Rica 3
DZ - Algeria 3
ET - Etiopia 3
PY - Paraguay 3
SN - Senegal 3
UY - Uruguay 3
AU - Australia 2
AZ - Azerbaigian 2
BE - Belgio 2
EE - Estonia 2
HU - Ungheria 2
KE - Kenya 2
KG - Kirghizistan 2
LB - Libano 2
LK - Sri Lanka 2
MT - Malta 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AL - Albania 1
BF - Burkina Faso 1
BW - Botswana 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
GH - Ghana 1
GT - Guatemala 1
LV - Lettonia 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
PS - Palestinian Territory 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TW - Taiwan 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 12.751
Salva come PNG Salva come JPEG
Città #
Moscow 1.833
Singapore 523
Santa Clara 448
San Jose 437
Hong Kong 430
Dublin 368
Ashburn 209
Chandler 189
Ho Chi Minh City 177
Hefei 173
Seoul 162
Hanoi 130
New York 115
Naples 80
Beijing 76
Bengaluru 67
Los Angeles 60
Princeton 49
Roxbury 49
The Dalles 49
Munich 47
Bremen 41
Dallas 36
Council Bluffs 32
Cambridge 31
Rome 31
North Bergen 30
Da Nang 29
São Paulo 28
Milan 25
Aversa 22
Haiphong 22
Frankfurt am Main 21
Jacksonville 20
Napoli 20
Nuremberg 20
Falkenstein 18
Medford 18
Turku 18
Marano Di Napoli 17
Des Moines 16
Vienna 16
Atlanta 15
Chicago 15
Orem 15
Biên Hòa 14
Brooklyn 14
Toronto 14
Amsterdam 13
Caserta 13
Hyderabad 12
London 12
Chennai 11
Dhaka 11
Guangzhou 11
Memphis 11
Phoenix 11
Boardman 10
Brasília 10
Rio de Janeiro 10
Turin 10
Wilmington 10
Belo Horizonte 9
Curitiba 9
Johannesburg 9
Salvador 9
San Giovanni In Fiore 9
Tokyo 9
Denver 8
Helsinki 8
Ninh Bình 8
Shanghai 8
Stockholm 8
Thái Nguyên 8
Baghdad 7
Fortaleza 7
San Francisco 7
Buenos Aires 6
Casalnuovo di Napoli 6
Guayaquil 6
Hải Dương 6
Lappeenranta 6
Montreal 6
Nanjing 6
Pozzuoli 6
Quito 6
Seattle 6
Warsaw 6
Amman 5
Boston 5
Bắc Ninh 5
Cairo 5
Campinas 5
Changsha 5
Florence 5
Goiânia 5
Hai Bà Trưng 5
Hillsboro 5
Mexico City 5
Pagani 5
Totale 6.673
Salva come PNG Salva come JPEG
Nome #
Bisoprolol for treatment of symptomatic patients with obstructive hypertrophic cardiomyopathy. The BASIC (bisoprolol AS therapy in hypertrophic cardiomyopathy) study 265
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry 206
The Risk of Sudden Unexpected Cardiac Death in Children: Epidemiology, Clinical Causes, and Prevention 189
Advanced Heart Failure in Special Population—Pediatric Age 176
Combined Effect of Mediterranean Diet and Aerobic Exercise on Weight Loss and Clinical Status in Obese Symptomatic Patients with Hypertrophic Cardiomyopathy 169
Cardiovascular Involvement in mtDNA Disease: Diagnosis, Management, and Therapeutic Options 166
Beyond cholesterol metabolism: The pleiotropic effects of proprotein convertase subtilisin/kexin type 9 (PCSK9). Genetics, mutations, expression, and perspective for long-term inhibition 163
Multimodality Imaging in Cardiomyopathies with Hypertrophic Phenotypes 162
Role of the orexin system on arousal, attention, feeding behaviour and sleep disorders 160
Diagnosis and Management of Cardiovascular Involvement in Friedreich Ataxia 157
Natural history of left ventricular hypertrophy in infants of diabetic mothers 157
Diagnosis and Management of Cardiovascular Involvement in Fabry Disease 156
Aortopathies in mouse models of Pompe, Fabry and Mucopolysaccharidosis IIIB lysosomal storage diseases 155
Medical treatment of patients with hypertrophic cardiomyopathy: An overview of current and emerging therapy 154
Access-Site Crossover in Patients With Acute Coronary Syndrome Undergoing Invasive Management 153
Clinical, Genetic, and Histological Characterization of Patients with Rare Neuromuscular and Mitochondrial Diseases Presenting with Different Cardiomyopathy Phenotypes 148
The Heart Muscle and Valve Involvement in Marfan Syndrome, Loeys-Dietz Syndromes, and Collagenopathies 147
Combined Clinical, Molecular, and Muscle Biopsy Approach to Unveil Prevalence and Clinical Features of Rare Neuromuscular and Mitochondrial Diseases in Patients With Cardiomyopathies 145
Effect of beta-blockers and angiotensin receptor blockers in reducing the aortic growth rate in children with bicuspid aortic valve-related aortopathy 138
Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis 134
Diagnosis and Management of Rare Cardiomyopathies in Adult and Paediatric Patients. A Position Paper of the Italian Society of Cardiology (SIC) and Italian Society of Paediatric Cardiology (SICP) 134
Natural History of Hypertrophic Cardiomyopathy in Noonan Syndrome With Multiple Lentigines 133
Aortic Root Diameter in Highly-Trained Competitive Athletes: Reference Values According to Sport and Prevalence of Aortic Enlargement 133
An atypical Aymé-Gripp phenotype detected by exome sequencing 133
Aetiology and clinical manifestations of patients with non-dilated left ventricular cardiomyopathy 131
Prevalence and clinical significance of right ventricular pulmonary arterial uncoupling in cardiac amyloidosis 131
The Role of Genetic Testing in Patients with Heritable Thoracic Aortic Diseases 130
Low-Dose Ticagrelor in Patients With High Ischemic Risk and Previous Myocardial Infarction: A Multicenter Prospective Real-World Observational Study 129
Multidisciplinary In-Depth Investigation in a Young Athlete Suffering from Syncope Caused by Myocardial Bridge 128
Pathophysiology, Functional Assessment and Prognostic Implications of Nutritional Disorders in Systemic Amyloidosis 127
Multimodality Imaging in Arrhythmogenic Left Ventricular Cardiomyopathy 125
Clinical Manifestations of 22q11.2 Deletion Syndrome 125
Immune-Checkpoint Inhibitor-Related Myocarditis: Where We Are and Where We Will Go 124
A complex unit for a complex disease: The HCM-Family Unit 122
Cardiovascular Involvement in Fabry's Disease: New Advances in Diagnostic Strategies, Outcome Prediction and Management 122
Impact of GLA Variant Classification on the Estimated Prevalence of Fabry Disease: A Systematic Review and Meta-Analysis of Screening Studies 120
Patterns of Left Ventricular Remodelling in Children and Young Patients with Hypertrophic Cardiomyopathy 119
SYNERGISM OR COMPETITION BETWEEN ZINC AND CHROMIUM DIETARY LEVELS ON INSULIN ACTION MECHANISM. A METHOD TO INVESTIGATE 117
External validation of the increased wall thickness score for the diagnosis of cardiac amyloidosis 116
Global left ventricular myocardial work efficiency in heart failure patients with cardiac amyloidosis: Pathophysiological implications and role in differential diagnosis 116
Prevalence and Clinical Significance of Intraventricular Conduction Disturbances in Hospitalized Children 115
Effectiveness in the short-term of a novel nutraceutical for the management of hypercholesterolemia: an observational multicenter primary care experience 114
The Role of Echocardiography for the Clinical Diagnosis, Risk Stratification, and Management of Cardiac Amyloidosis 113
Left Ventricular Non-Compaction in Children: Aetiology and Diagnostic Criteria 111
Resistive index of central retinal artery, aortic arterial stiffness and OCTA correlated parameters in the early stage of fabry disease 111
Hypertrophic Cardiomyopathy in RASopathies: Diagnosis, Clinical Characteristics, Prognostic Implications, and Management 110
Genotype-Phenotype Correlations in ATTR Amyloidosis: A Clinical Update 108
Severe Lymphatic Disorder and Multifocal Atrial Tachycardia Treated with Trametinib in a Patient with Noonan Syndrome and SOS1 Mutation 108
Targeted Therapies in Pediatric and Adult Patients With Hypertrophic Heart Disease: From Molecular Pathophysiology to Personalized Medicine 108
Prevalence and direct costs of patients with neuromyelitis optica: Data from Campania region in southern Italy 108
[Rare Diseases and epidemiology: an overlook at data from the Campania Region Rare Disease Registry (Southern Italy)] 108
Thoracic Aortic Dilation: Implications for Physical Activity and Sport Participation 107
Amyloid Cardiomyopathies: Clinical, Diagnostic, and Therapeutic Aspects 106
Yield and clinical significance of genetic screening in elite and amateur athletes 106
Artificial intelligence for left ventricular hypertrophy detection and differentiation on echocardiography, cardiac magnetic resonance and cardiac computed tomography: A systematic review 105
Lipoprotein(a): a genetic marker for cardiovascular disease and target for emerging therapies 101
Clinical pathway on pediatric cardiomyopathies: A genetic testing strategy proposed by the Italian Society of Pediatric Cardiology 100
The Role of New Imaging Technologies in the Diagnosis of Cardiac Amyloidosis 100
Prevalence and clinical significance of red flags in patients with hypertrophic cardiomyopathy 99
Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypes 98
Beta-blockers in heart failure prognosis: Lessons learned by MECKI Score Group papers 97
Diagnosis of Fabry Disease in a Patient with a Surgically Repaired Congenital Heart Defect: When Clinical History and Genetics Make the Difference 97
Athlete’s Heart: A Cardiovascular Step-By-Step Multimodality Approach 96
Treatment options for hypertrophic obstructive cardiomyopathy: a patient-centric review 95
Orexin system: Network multi-tasking 95
Prediction of incident atrial fibrillation in hypertrophic cardiomyopathy 94
Hypertrophic cardiomyopathy: prevalence of disease-specific red flags 94
ECG analysis in patients with acute coronary syndrome undergoing invasive management: rationale and design of the electrocardiography sub-study of the MATRIX trial 93
An Overview of Molecular Mechanisms in Fabry Disease 93
Potential role of imaging markers in predicting future disease expression of arrhythmogenic cardiomyopathy 92
Clinical manifestation of patients with Fabry disease and R356W GLA variant 91
Unexplained sudden cardiac arrest in children: clinical and genetic characteristics of survivors 90
A Roadmap to Predict Adverse Outcome in Fabry Disease 89
Hypertrophic Cardiomyopathy in Children: Pathophysiology, Diagnosis, and Treatment of Non-sarcomeric Causes 89
Prevalence of Pathogenic Variants in Cardiomyopathy-Associated Genes in Acute Myocarditis 88
Genetic evaluation in athletes and cascade family screening: reply 88
The role of genetic testing in Marfan syndrome 88
Rare Cardiovascular Diseases: From Genetics to Personalized Medicine 87
Current Management of Transition and Multidisciplinary Care of Patients with Inherited and Rare Cardiomyopathies in Europe: Results of the European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARD-HEART) 86
Clinical significance of family history and bicuspid aortic valve in children and young adult patients with Marfan syndrome 86
Impact of Regular Physical Activity on Aortic Diameter Progression in Paediatric Patients with Bicuspid Aortic Valve 86
Sport activity in patients with cardiomyopathies: a review 83
Molecular Basis of Inflammation in the Pathogenesis of Cardiomyopathies 83
Prognostic Implications of Declining Hemoglobin Content in Patients Hospitalized With Acute Coronary Syndromes 83
Left ventricular rotational mechanics in cardiac amyloidosis - reply 81
Implantable cardioverter defibrillator in hypertrophic cardiomyopathy: Time to avoid unnecessary procedure 81
From the phenotype to precision medicine: an update on the cardiomyopathies diagnostic workflow 78
Modified Body Mass Index as a Novel Nutritional and Prognostic Marker in Patients with Cardiac Amyloidosis 78
Editorial: Paediatric Cardiomyopathies 78
Prediction of radial crossover in acute coronary syndromes: Derivation and validation of the MATRIX score 78
Sudden cardiac death risk prediction in Fabry disease: How many strings do we have on our bow? 77
Is There a Role for Genetic Testing in Patients With Myocarditis? 77
Rare case of Kawasaki disease with cardiac tamponade and giant coronary artery aneurysms 76
Hypertrophic Cardiomyopathy-Current Challenges and Future Perspectives 75
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population 75
The heart in RASopathies 74
The Prognostic Role of Pulmonary Arterial Elastance in Patients Undergoing Left Ventricular Assist Device Implantation: A Pilot Study 74
Prevalence and cardiovascular outcomes of left ventricular hypertrabeculation in children 74
Prevalence and clinical implications of hyperhomocysteinaemia in patients with hypertrophic cardiomyopathy and MTHFR C6777T polymorphism 74
Editorial: Cardiovascular genetics-focus on paediatric cardiomyopathy 71
Totale 11.335
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.276
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.276
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022330 0 3 2 18 91 12 11 28 9 25 21 110
2022/2023703 76 54 8 38 82 36 4 42 324 5 19 15
2023/2024487 20 13 13 29 106 112 13 42 9 12 24 94
2024/20251.958 8 12 4 39 332 268 237 179 309 230 195 145
2025/20269.016 450 511 432 347 699 4.608 616 438 344 263 181 127
2026/2027303 66 237 0 0 0 0 0 0 0 0 0 0
Totale 13.008